News Renovaro Inc.

Equities

RENB

US29350E1047

Real-time Estimate Cboe BZX Other stock markets 12:21:08 2024-04-24 pm EDT			5-day change	1st Jan Change
2.01 ^USD	-0.50%		-9.46%	-36.59%

Apr. 18	Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	CI
Mar. 13	Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care	Apr. 18	GL
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	Apr. 18	CI
Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer	Mar. 13	CI
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	Mar. 11	PR
Renovaro Inc. Announces Resignation of Luisa Puche as Chief Financial Officer, Effective as of March 21, 2024	Mar. 05	CI
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	Mar. 03	PR
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	Feb. 25	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	Feb. 24	PR
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	Feb. 16	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	Feb. 15	PR
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace	Feb. 15	GL
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14	CI
Renovaro Inc. Announces Board Changes	Feb. 14	CI
Sector Update: Health Care Stocks Gain Late Afternoon	Feb. 14	MT
Sector Update: Health Care	Feb. 14	MT
Renovaro Shares Jump After Response to Short Seller Hindenburg's Report	Feb. 14	MT
Statement of Renovaro Inc	Feb. 14	GL
Sector Update: Health Care Stocks Decline Late Afternoon	Feb. 13	MT
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB	Feb. 13	BU
Renovaro's GEDi Cube Agrees to Acquire 75% Stake in Cyclomics	Feb. 13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Renovaro Inc.

Equities

RENB

US29350E1047

Summary

Filters